 |
Prostaglandin E1 in lipid emulsion |
|---|---|
| Trade Name | Lipo-Pge1 |
| Orphan Indication | Ischemic ulceration of the lower limbs due to peripheral arterial disease |
| USA Market Approval | USA |
| USA Designation Date | 1996-09-10 00:00:00 |
| Sponsor | Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 |
